Jaguar Health (HAM:1JA) EV-to-Revenue : 4.15 (As of Jun. 04, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Jaguar Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Jaguar Health's enterprise value is €38.95 Mil. Jaguar Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €9.38 Mil. Therefore, Jaguar Health's EV-to-Revenue for today is 4.15.

The historical rank and industry rank for Jaguar Health's EV-to-Revenue or its related term are showing as below:

HAM:1JA' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.94 Med: 3.78 Max: 46.9
Current: 4.17

During the past 11 years, the highest EV-to-Revenue of Jaguar Health was 46.90. The lowest was 1.94. And the median was 3.78.

HAM:1JA's EV-to-Revenue is ranked better than
65.9% of 1038 companies
in the Biotechnology industry
Industry Median: 8.075 vs HAM:1JA: 4.17

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-04), Jaguar Health's stock price is €7.254. Jaguar Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €15.25. Therefore, Jaguar Health's PS Ratio for today is 0.48.

Jaguar Health EV-to-Revenue Historical Data

The historical data trend for Jaguar Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jaguar Health EV-to-Revenue Chart

Jaguar Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.99

10.29

14.49

3.59

4.27

Jaguar Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															2.58	2.99	3.62	4.27	4.56

Competitive Comparison of Jaguar Health's EV-to-Revenue

For the Biotechnology subindustry, Jaguar Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jaguar Health's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jaguar Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Jaguar Health's EV-to-Revenue falls into.

Jaguar Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Jaguar Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	38.950	/	9.378
	=	4.15

Jaguar Health's current Enterprise Value is €38.95 Mil.
Jaguar Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.38 Mil.

Jaguar Health (HAM:1JA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Jaguar Health's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	7.254	/	15.251
	=	0.48

Jaguar Health's share price for today is €7.254.
Jaguar Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.25.

Jaguar Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jaguar Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Jaguar Health (HAM:1JA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jaguar Health Inc (HAM:1JA) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

JAGX:USA 1JAA:Germany

Address

200 Pine Street, Suite 400, San Francisco, CA, USA, 94104

Website

http://www.jaguar.health

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments-human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Jaguar Health (HAM:1JA) Headlines

No Headlines